社区
首页
集团介绍
社区
资讯
行情
学堂
TigerAI
登录
注册
Atai Beckley Inc(ATAI)
7.17
+0.02
+0.28%
行情数据延迟15分钟
社区
社区
资讯
资讯
资料
资料
公告
公告
最新
推荐
科迪勒拉
·
05-13
特朗普政策加持，毒蘑菇有望迎来上市审批？
今天聊聊两家毒蘑菇股票：CMPS与CYBN
$COMPASS Pathways plc(CMPS)$
$Cybin Inc(HELP)$
一、政策面：特朗普签署行政令，FDA已落地执行 2026年4月18日，特朗普签署行政令，要求FDA加速推进迷幻药用于严重精神疾病的审评审批。核心措施包括： · 设立国家优先审评券（CNPV），将常规10-12个月的审评周期压缩至1-2个月。 · 启动滚动审评机制，允许NDA阶段数据边整理边提交。 · 拨款不少于5000万美元资助相关临床研究。 · DEA配合启动I类管控药物的重新分类程序，为商业化上市清理障碍。 4月24日，FDA授予三款迷幻药CNPV资格，包括CMPS的COMP360、Usona Institute的psilocybin以及另一家公司的methylone。FDA局长特别指出，COMP360因其已完成两项大型安慰剂对照III期试验，验证了快速起效和至少6个月的疗效可持续性，25mg剂量在MADRS评分上与1mg对照组的分离达到统计学显著性。 二、CMPS：最接近NDA提交的TRD靶向药物 CMPS的COMP360是全球唯一在难治性抑郁症（TRD）人群中完成两项阳性III期试验的合成赛洛西宾制剂。两项III期数据显示：单次25mg给药后次日即出现具统计意义的快速起效，疗效可持续至6个月以上；安全性良好，不良事件以轻中度为主，24小时内消退，无严重信号。 基于上述数据，FDA已批准CMPS的NDA滚动提交和CNPV资格，审评窗口将从常规周期大幅压缩至1-2个月。 时间线上，CMPS将在2026年第三季度读出COMP006的26周持久性数据，这将是NDA申报的最终数据集。
特朗普政策加持，毒蘑菇有望迎来上市审批？
精彩
EugeneRodriguez:
这题材太野了 你真敢拿到审批前吗
回复
2
点赞
2
编组 21备份 2
分享
举报
runningWater
·
2025-10-24
$ATAI Life Sciences B.V.*(ATAI)$
进了些
$ATAI Life Sciences B.V.*(ATAI)$ 进了些
回复
评论
点赞
1
编组 21备份 2
分享
举报
木头姐每天交易了什么
·
2025-10-18
木头姐抄底买入30万美元中概股小马智行 买入400万美元ATAI 卖出440万美元RKLB(火箭实验室)
昨天的美股反反复复，上下震荡，下午4点多我在外面忙事，掏出手机一看整个都绿了，跌幅还挺大的。有些科技股都跌到我心里价位。晚上开盘，一下跌，一下涨，反复拉锯。港股没中签，剩下资金那就抄个科技股先放着😃 包括昨天说的银行信贷危机，这哪是危机，小题大做而已，美国发达的市场最不缺的就是银行业。进入10月以来真的是震荡行情，隔三差五有个好价格做T，要抄木头姐作业的也别全买入了，可能下周又出什么幺儿子😓 木头姐买入400万美元左右ATAI，看日均线走势挺不错的，很像KTOS的走势。叠加公司因其用于治疗难治性抑郁症的鼻喷雾剂获得了FDA授予的突破性疗法认定。想起老东家做的医疗按摩产品，在亚马逊上售卖总是被下架，就是没有FDA的510K认证，只能在描述里删除医疗相关的词，整得文案像四不像🙂↕️ 买入30万美元小马智行，最近是要在香港上市了吗，看到刚通过聆讯，买入430万美元DE。 卖出440万美元RKLB、好多人是想投资SpaceX的，但是有些门槛达不到，这个股在外网上有好几个人分析过，潜力还是有的。卖出130万美元TEM、130万美元NTRA、65万美元SOFI。
木头姐抄底买入30万美元中概股小马智行 买入400万美元ATAI 卖出440万美元RKLB(火箭实验室)
回复
评论
点赞
2
编组 21备份 2
分享
举报
加载更多
公司概况
公司名称
Atai Beckley Inc
所属市场
NASDAQ
成立日期
- -
员工人数
- -
办公地址
- -
公司网址
http://www.ataibeckley.com;ir.ataibeckley.com
邮政编码
- -
联系电话
- -
联系传真
- -
公司概况
AtaiBeckley Inc.于2020年9月10日根据荷兰法律注册。2021年1月11日，更名为ATAI Life Sciences B.V.。2025年11月5日，更名为Atai Beckley N.V.。2026年1月2日，公司名称变更为AtaiBeckley Inc.，并转变为根据特拉华州法律注册成立的公司。该公司是一家临床阶段的生物技术公司，专注于为难以治疗的心理健康疾病开发新型的、基于迷幻药的神经可塑性药物。其研发管线包括针对难治性抑郁症和社交焦虑障碍的研究项目，以及一个针对新型非致幻化合物的药物发现项目。
07-16 12:00
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
07-07
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
06-26
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
06-25
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
06-08
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
06-03
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
05-13
季度报告
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
05-12
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
04-20
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
03-20
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
03-11
关联方拟减持公告
Form 144 - Report of proposed sale of securities
Form 144 - Report of proposed sale of securities
03-09
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
03-06
重要事件披露
Form 8-K - Current report
Form 8-K - Current report
03-06
年度报告
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
03-06
员工持股计划
Form S-8 - Securities to be offered to employees in employee benefit plans
Form S-8 - Securities to be offered to employees in employee benefit plans
分时
5日
日
周
月
数据加载中...
最高
7.18
今开
7.08
量比
2.19
最低
7.08
昨收
7.15
换手率
4.37%
热议股票
{"pagemeta":{"title":"Atai Beckley Inc(ATAI)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Atai Beckley Inc(ATAI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Atai Beckley Inc,ATAI,Atai Beckley Inc股票,Atai Beckley Inc股票老虎,Atai Beckley Inc股票老虎国际,Atai Beckley Inc行情,Atai Beckley Inc股票行情,Atai Beckley Inc股价,Atai Beckley Inc股市,Atai Beckley Inc股票价格,Atai Beckley Inc股票交易,Atai Beckley Inc股票购买,Atai Beckley Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Atai Beckley Inc(ATAI)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Atai Beckley Inc(ATAI)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}},"tab":"community","symbol":"ATAI","data":{"stockData":{"symbol":"ATAI","market":"US","secType":"STK","nameCN":"Atai Beckley Inc","latestPrice":7.17,"timestamp":1784298315819,"preClose":7.15,"halted":0,"volume":12889672,"delay":0,"changeRate":0.0027972027972027374,"floatShares":295190905,"shares":367000000,"eps":-2.440574,"marketStatus":"交易中","change":0.02,"latestTime":"07-17 10:25:16 EDT","open":7.08,"high":7.18,"low":7.08,"amount":91928521.999744,"amplitude":0.013986,"askPrice":7.17,"askSize":7844,"bidPrice":7.16,"bidSize":27070,"shortable":3,"etf":0,"ttmEps":-2.440574,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1784318400000},"marketStatusCode":2,"adr":1,"adrRate":2,"listingDate":1623988800000,"exchange":"NASDAQ","adjPreClose":7.15,"preHourTrading":{"tag":"盘前","latestPrice":7.08,"preClose":7.15,"latestTime":"09:29 EDT","volume":513073,"amount":3635844.611784,"timestamp":1784294999999,"change":-0.07,"changeRate":-0.00979,"amplitude":0.011245},"postHourTrading":{"tag":"盘后","latestPrice":7.086,"preClose":7.15,"latestTime":"19:59 EDT","volume":1153138,"amount":8213160.6352,"timestamp":1784246384458,"change":-0.064,"changeRate":-0.008951,"amplitude":0.011189},"volumeRatio":2.193401,"impliedVol":0.2843,"impliedVolPercentile":0.004},"tweetData":{"bottom":false,"list":[{"cardType":"TWEET","cardId":"TWEET.563674980410800","cardData":[{"tweetId":"563674980410800","author":{"authorId":"3484536045691836","idStr":"3484536045691836","name":"科迪勒拉","avatar":"https://static.tigerbbs.com/3f226f5fd9da51c5782d3e591f0bfe54","userType":2,"introduction":"倾向于进入好的业务，并安静地留在那里。","crmLevel":3,"crmLevelSwitch":0,"individualDisplayBadges":[{"badgeId":"3f8f4b8c193b4343a88817ce07587dbd-1","templateUuid":"3f8f4b8c193b4343a88817ce07587dbd","name":"星级创作者","description":"累计发表精华帖>=3（或有料帖>=10），且30天内发表过至少一篇精华帖（或4篇有料帖）并参与过评论","bigImgUrl":"https://static.tigerbbs.com/1866dcf97a73be1c330f85862546aedc","smallImgUrl":"https://static.tigerbbs.com/4f5c5fa8e2c7683bb5a7fce8753ee456","redirectLinkEnabled":1,"redirectLink":"https://www.laohu8.com/activity/market/2023/star-contributors/","hasAllocated":1,"isWearing":0,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2026.07.17","individualDisplayEnabled":1,"backgroundColor":{"dark":"#675a37","tint":"#f9ebc2"},"fontColor":{"dark":"#ffffff","tint":"#ab7a0e"},"individualDisplaySort":1}],"wearingBadges":[],"fanSize":4387,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"特朗普政策加持，毒蘑菇有望迎来上市审批？","digest":"今天聊聊两家毒蘑菇股票：CMPS与CYBN <a href=\"https://laohu8.com/S/CMPS\">$COMPASS Pathways plc(CMPS)$</a> <a href=\"https://laohu8.com/S/HELP\">$Cybin Inc(HELP)$</a> 一、政策面：特朗普签署行政令，FDA已落地执行 2026年4月18日，特朗普签署行政令，要求FDA加速推进迷幻药用于严重精神疾病的审评审批。核心措施包括： · 设立国家优先审评券（CNPV），将常规10-12个月的审评周期压缩至1-2个月。 · 启动滚动审评机制，允许NDA阶段数据边整理边提交。 · 拨款不少于5000万美元资助相关临床研究。 · DEA配合启动I类管控药物的重新分类程序，为商业化上市清理障碍。 4月24日，FDA授予三款迷幻药CNPV资格，包括CMPS的COMP360、Usona Institute的psilocybin以及另一家公司的methylone。FDA局长特别指出，COMP360因其已完成两项大型安慰剂对照III期试验，验证了快速起效和至少6个月的疗效可持续性，25mg剂量在MADRS评分上与1mg对照组的分离达到统计学显著性。 二、CMPS：最接近NDA提交的TRD靶向药物 CMPS的COMP360是全球唯一在难治性抑郁症（TRD）人群中完成两项阳性III期试验的合成赛洛西宾制剂。两项III期数据显示：单次25mg给药后次日即出现具统计意义的快速起效，疗效可持续至6个月以上；安全性良好，不良事件以轻中度为主，24小时内消退，无严重信号。 基于上述数据，FDA已批准CMPS的NDA滚动提交和CNPV资格，审评窗口将从常规周期大幅压缩至1-2个月。 时间线上，CMPS将在2026年第三季度读出COMP006的26周持久性数据，这将是NDA申报的最终数据集。","plainDigest":"今天聊聊两家毒蘑菇股票：CMPS与CYBN $COMPASS Pathways plc(CMPS)$ $Cybin Inc(HELP)$ 一、政策面：特朗普签署行政令，FDA已落地执行 2026年4月18日，特朗普签署行政令，要求FDA加速推进迷幻药用于严重精神疾病的审评审批。核心措施包括： · 设立国家优先审评券（CNPV），将常规10-12个月的审评周期压缩至1-2个月。 · 启动滚动审评机制，允许NDA阶段数据边整理边提交。 · 拨款不少于5000万美元资助相关临床研究。 · DEA配合启动I类管控药物的重新分类程序，为商业化上市清理障碍。 4月24日，FDA授予三款迷幻药CNPV资格，包括CMPS的COMP360、Usona Institute的psilocybin以及另一家公司的methylone。FDA局长特别指出，COMP360因其已完成两项大型安慰剂对照III期试验，验证了快速起效和至少6个月的疗效可持续性，25mg剂量在MADRS评分上与1mg对照组的分离达到统计学显著性。 二、CMPS：最接近NDA提交的TRD靶向药物 CMPS的COMP360是全球唯一在难治性抑郁症（TRD）人群中完成两项阳性III期试验的合成赛洛西宾制剂。两项III期数据显示：单次25mg给药后次日即出现具统计意义的快速起效，疗效可持续至6个月以上；安全性良好，不良事件以轻中度为主，24小时内消退，无严重信号。 基于上述数据，FDA已批准CMPS的NDA滚动提交和CNPV资格，审评窗口将从常规周期大幅压缩至1-2个月。 时间线上，CMPS将在2026年第三季度读出COMP006的26周持久性数据，这将是NDA申报的最终数据集。","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1778650299948,"gmtModify":1778650635923,"symbols":["HELP","CMPS","ATAI","LENZ"],"themeIds":[],"popularizeThemeFlag":false,"imageCount":0,"images":[],"repostCount":0,"viewCount":17404,"likeCount":2,"liked":false,"collected":false,"commentCount":2,"hotComments":[{"id":"563685144400680","author":{"authorId":"9000000000000178","idStr":"9000000000000178","name":"EugeneRodriguez","avatar":"https://static.tigerbbs.com/04221b7d7c3696fc0494449aa000899e","userType":8,"introduction":"运营账号","crmLevel":1,"crmLevelSwitch":0,"fanSize":19,"starInvestorFlag":false},"content":"这题材太野了 你真敢拿到审批前吗","plainContent":"这题材太野了 你真敢拿到审批前吗","likeCount":0,"commentType":"valid","coins":0}],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":true,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/563674980410800","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":2219,"displayRows":4,"foldSize":0,"authorId":"3484536045691836"}]},{"cardType":"TWEET","cardId":"TWEET.492508146045304","cardData":[{"tweetId":"492508146045304","author":{"authorId":"3481198532251791","idStr":"3481198532251791","name":"runningWater","avatar":"https://static.tigerbbs.com/8d4934986d84ea6b46cbb12a870521e4","userType":1,"introduction":"","crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[],"wearingBadges":[],"fanSize":5,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"","digest":"<a href=\"https://laohu8.com/S/ATAI\">$ATAI Life Sciences B.V.*(ATAI)$</a> 进了些","plainDigest":"$ATAI Life Sciences B.V.*(ATAI)$ 进了些","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1761261842470,"gmtModify":1761261845005,"symbols":["ATAI"],"themeIds":["5bfad02ab61749c8bfe6573ac7bbe8a3"],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/b2f8ec7e5455dc0b903c316e4fabc250","width":"981","height":"1637"}],"repostCount":0,"viewCount":3038,"likeCount":1,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":false,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/492508146045304","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":["晒单贴"],"commentAndTweetFlag":false,"upFlag":false,"length":35,"displayRows":4,"foldSize":0,"authorId":"3481198532251791"}]},{"cardType":"TWEET","cardId":"TWEET.490614185754720","cardData":[{"tweetId":"490614185754720","author":{"authorId":"3501635951396291","idStr":"3501635951396291","name":"木头姐每天交易了什么","avatar":"https://static.tigerbbs.com/5a47ea428cf7912b7c26a4cd13a243ef","userType":1,"introduction":"","userGiftHeadFrame":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":4,"crmLevelSwitch":0,"wearingBadge":{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-4","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"Tiger Star","description":"Join the tiger community for 2000 days","bigImgUrl":"https://static.tigerbbs.com/dddf24b906c7011de2617d4fb3f76987","smallImgUrl":"https://static.tigerbbs.com/53d58ad32c97254c6f74db8b97e6ec49","grayImgUrl":"https://static.tigerbbs.com/6304700d92ad91c7a33e2e92ec32ecc1","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.03.25","individualDisplayEnabled":0,"individualDisplaySort":0},"individualDisplayBadges":[],"wearingBadges":[],"fanSize":1165,"starInvestorFlag":false,"userFollowAuthorFlag":false,"authorFollowUserFlag":false},"userFollowAuthorFlag":false,"authorFollowUserFlag":false,"title":"木头姐抄底买入30万美元中概股小马智行 买入400万美元ATAI 卖出440万美元RKLB(火箭实验室) ","digest":"昨天的美股反反复复，上下震荡，下午4点多我在外面忙事，掏出手机一看整个都绿了，跌幅还挺大的。有些科技股都跌到我心里价位。晚上开盘，一下跌，一下涨，反复拉锯。港股没中签，剩下资金那就抄个科技股先放着😃 包括昨天说的银行信贷危机，这哪是危机，小题大做而已，美国发达的市场最不缺的就是银行业。进入10月以来真的是震荡行情，隔三差五有个好价格做T，要抄木头姐作业的也别全买入了，可能下周又出什么幺儿子😓 木头姐买入400万美元左右ATAI，看日均线走势挺不错的，很像KTOS的走势。叠加公司因其用于治疗难治性抑郁症的鼻喷雾剂获得了FDA授予的突破性疗法认定。想起老东家做的医疗按摩产品，在亚马逊上售卖总是被下架，就是没有FDA的510K认证，只能在描述里删除医疗相关的词，整得文案像四不像🙂↕️ 买入30万美元小马智行，最近是要在香港上市了吗，看到刚通过聆讯，买入430万美元DE。 卖出440万美元RKLB、好多人是想投资SpaceX的，但是有些门槛达不到，这个股在外网上有好几个人分析过，潜力还是有的。卖出130万美元TEM、130万美元NTRA、65万美元SOFI。","plainDigest":"昨天的美股反反复复，上下震荡，下午4点多我在外面忙事，掏出手机一看整个都绿了，跌幅还挺大的。有些科技股都跌到我心里价位。晚上开盘，一下跌，一下涨，反复拉锯。港股没中签，剩下资金那就抄个科技股先放着😃 包括昨天说的银行信贷危机，这哪是危机，小题大做而已，美国发达的市场最不缺的就是银行业。进入10月以来真的是震荡行情，隔三差五有个好价格做T，要抄木头姐作业的也别全买入了，可能下周又出什么幺儿子😓 木头姐买入400万美元左右ATAI，看日均线走势挺不错的，很像KTOS的走势。叠加公司因其用于治疗难治性抑郁症的鼻喷雾剂获得了FDA授予的突破性疗法认定。想起老东家做的医疗按摩产品，在亚马逊上售卖总是被下架，就是没有FDA的510K认证，只能在描述里删除医疗相关的词，整得文案像四不像🙂↕️ 买入30万美元小马智行，最近是要在香港上市了吗，看到刚通过聆讯，买入430万美元DE。 卖出440万美元RKLB、好多人是想投资SpaceX的，但是有些门槛达不到，这个股在外网上有好几个人分析过，潜力还是有的。卖出130万美元TEM、130万美元NTRA、65万美元SOFI。","sourceLanguage":"CN","currentLanguage":"CN","editable":false,"auditStatus":"PASSED","topFlag":false,"totalScore":0,"gmtCreate":1760779712338,"gmtModify":1760779727999,"symbols":["RKLB","ATAI","PONY","TTTN"],"themeIds":["d3ffb4320f5146dba631ced272db1649"],"popularizeThemeFlag":false,"imageCount":1,"images":[{"url":"https://static.tigerbbs.com/0a82d5cecac016047f05d403fde2be92","width":"1232","height":"1150"}],"repostCount":0,"viewCount":5489,"likeCount":2,"liked":false,"collected":false,"commentCount":0,"hotComments":[],"voteFlag":false,"rewardFlag":false,"videoFlag":false,"articleFlag":false,"paperFlag":true,"essentialFlag":false,"highlightedFlag":false,"shareLink":"https://laohu8.com/post/490614185754720","orderFlag":false,"starInvestorRankings":[],"featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":853,"displayRows":4,"foldSize":0,"authorId":"3501635951396291"}]}],"size":3},"newsData":null,"noticeData":{"listData":[{"cdn_pdf":false,"hasAttachments":true,"id":"21510530","market":"us","labels":[],"media":"sec.gov","original_id":"AN114036126028604-ATAI","pdf_url":"","pub_time":1784174400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ATAI","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126028604/0001140361-26-028604-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 2.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126028604/ef20078103_ex2-1.htm","primary":true,"translateUrl":"","linkName":"ef20078103_ex2-1.htm","type":"EX-2.1","id":"NTFILE4EggLTbAapPM4yrt","market":"us","size":794070},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126028604/ef20078103_8k.htm","primary":false,"translateUrl":"","linkName":"ef20078103_8k.htm","type":"8-K","id":"NTFILEGbD8M2as2M6fi6oc","market":"us","size":71189},{"description":"EXHIBIT 10.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126028604/ef20078103_ex10-1.htm","primary":false,"translateUrl":"","linkName":"ef20078103_ex10-1.htm","type":"EX-10.1","id":"NTFILEGMGnekJbVYoebnX4","market":"us","size":82734},{"description":"EXHIBIT 99.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126028604/ef20078103_ex99-1.htm","primary":false,"translateUrl":"","linkName":"ef20078103_ex99-1.htm","type":"EX-99.1","id":"NTFILEDj3pmoKJZSpJNahy","market":"us","size":29208},{"description":"","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126028604/image01.jpg","primary":false,"translateUrl":"","linkName":"image01.jpg","type":"GRAPHIC","id":"NTFILE8urXAZQvGJtJa1wF","market":"us","size":3394},{"description":"","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126028604/image02.jpg","primary":false,"translateUrl":"","linkName":"image02.jpg","type":"GRAPHIC","id":"NTFILED2fgJutYqSmKxLME","market":"us","size":4683}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-07-16 12:00","pubTimestamp":1784174400,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 7.01: Regulation FD Disclosure;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目1.01：签订实质性最终协议；项目7.01：法规FD披露；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21481035","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004726006940-ATAI","pdf_url":"","pub_time":1783396800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"ATAI","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2081043/000195004726006940/0001950047-26-006940-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1274139/000195004726006940/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE951XyJeRTLekkR2n","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-07-07 12:00","pubTimestamp":1783396800,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21439062","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004726006539-ATAI","pdf_url":"","pub_time":1782446400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"ATAI","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2081043/000195004726006539/0001950047-26-006539-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2047433/000195004726006539/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILEa5ZwVThiR8w5vPXb","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-06-26 12:00","pubTimestamp":1782446400,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21432626","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004726006513-ATAI","pdf_url":"","pub_time":1782360000000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"ATAI","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2081043/000195004726006513/0001950047-26-006513-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2049601/000195004726006513/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILECP1NPF699ShniBBn","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-06-25 12:00","pubTimestamp":1782360000,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21369801","market":"us","labels":[],"media":"sec.gov","original_id":"AN114036126024474-ATAI","pdf_url":"","pub_time":1780891200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ATAI","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126024474/0001140361-26-024474-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126024474/ef20075614_8k.htm","primary":true,"translateUrl":"","linkName":"ef20075614_8k.htm","type":"8-K","id":"NTFILEHAEeZk2DqxanMWZh","market":"us","size":36853}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-06-08 12:00","pubTimestamp":1780891200,"title_zh":"Form 8-K - Current report","summary_en":"Item 5.07: Submission of Matters to a Vote of Security Holders","summary_zh":"项目5.07：将事项提交证券持有人表决","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21350222","market":"us","labels":[],"media":"sec.gov","original_id":"AN114036126023815-ATAI","pdf_url":"","pub_time":1780459200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ATAI","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126023815/0001140361-26-023815-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 7.01: Regulation FD Disclosure","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"8-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126023815/ef20075362_8k.htm","primary":true,"translateUrl":"","linkName":"ef20075362_8k.htm","type":"8-K","id":"NTFILE6hCdRMoWtr2aD1XA","market":"us","size":33677}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-06-03 12:00","pubTimestamp":1780459200,"title_zh":"Form 8-K - Current report","summary_en":"Item 7.01: Regulation FD Disclosure","summary_zh":"第7.01项：法规FD披露","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21249077","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312526219412-ATAI","pdf_url":"","pub_time":1778616559000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","symbol":"ATAI","title":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","titleType":"季度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/2081043/0001193125-26-219412-index.html","us_notice_code":"Form 10-Q","us_title_en":"Form 10-Q - Quarterly report [Sections 13 or 15(d)]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-Q","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000119312526219412/atai-20260331.htm","primary":true,"translateUrl":"","linkName":"atai-20260331.htm","type":"10-Q","id":"NTFILE9f1dP8hvVvx4iRFr","market":"us","size":3205004},{"description":"EX-31.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000119312526219412/atai-ex31_1.htm","primary":false,"translateUrl":"","linkName":"atai-ex31_1.htm","type":"EX-31.1","id":"NTFILEBS6b9FFd74krJweD","market":"us","size":16277},{"description":"EX-31.2","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000119312526219412/atai-ex31_2.htm","primary":false,"translateUrl":"","linkName":"atai-ex31_2.htm","type":"EX-31.2","id":"NTFILE2EXtACw4ebxWgZQ7","market":"us","size":17628},{"description":"EX-32.1","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000119312526219412/atai-ex32_1.htm","primary":false,"translateUrl":"","linkName":"atai-ex32_1.htm","type":"EX-32.1","id":"NTFILEEcZ1gKoK2GU6neXm","market":"us","size":10382},{"description":"EX-32.2","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000119312526219412/atai-ex32_2.htm","primary":false,"translateUrl":"","linkName":"atai-ex32_2.htm","type":"EX-32.2","id":"NTFILEBxds1fpAx81uXTdp","market":"us","size":10143},{"description":"GRAPHIC","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000119312526219412/img165310728_0.jpg","primary":false,"translateUrl":"","linkName":"img165310728_0.jpg","type":"GRAPHIC","id":"NTFILEDh6bhCNeUYQN9GCq","market":"us","size":164970}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Quarterly Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"季度报告","pubTime":"2026-05-13 04:09","pubTimestamp":1778616559,"title_zh":"Form 10-Q - Quarterly report [Sections 13 or 15(d","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21245551","market":"us","labels":[],"media":"sec.gov","original_id":"AN114036126020708-ATAI","pdf_url":"","pub_time":1778558400000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ATAI","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126020708/0001140361-26-020708-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126020708/ef20072731_ex99-1.htm","primary":true,"translateUrl":"","linkName":"ef20072731_ex99-1.htm","type":"EX-99.1","id":"NTFILE39nB6VgdBWVVgdJD","market":"us","size":126525},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126020708/ef20072731_8k.htm","primary":false,"translateUrl":"","linkName":"ef20072731_8k.htm","type":"8-K","id":"NTFILEA62t61RcfNVgbMCn","market":"us","size":30004}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-05-12 12:00","pubTimestamp":1778558400,"title_zh":"Form 8-K - Current report","summary_en":"Item 2.02: Results of Operations and Financial Condition;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目2.02：经营业绩和财务状况；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"21039311","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004726003650-ATAI","pdf_url":"","pub_time":1776657600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"ATAI","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2081043/000195004726003650/0001950047-26-003650-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2049601/000195004726003650/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILEApdQSMxmD3XdFraz","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-04-20 12:00","pubTimestamp":1776657600,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20868072","market":"us","labels":[],"media":"sec.gov","original_id":"AN195004726002874-ATAI","pdf_url":"","pub_time":1773979200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"ATAI","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/1840904/000195004726002874/0001950047-26-002874-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/1840904/000195004726002874/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILEASVCbKvhrtAXCeMe","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-03-20 12:00","pubTimestamp":1773979200,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20989167","market":"us","labels":[],"media":"sec.gov","original_id":"AN197248126000098-ATAI","pdf_url":"","pub_time":1773201600000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 144 - Report of proposed sale of securities","symbol":"ATAI","title":"Form 144 - Report of proposed sale of securities","titleType":"关联方拟减持公告","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2081043/000197248126000098/0001972481-26-000098-index.htm","us_notice_code":"Form 144","us_title_en":"Form 144 - Report of proposed sale of securities","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000197248126000098/xsl144X01/primary_doc.xml","primary":true,"translateUrl":"","linkName":"primary_doc.html","type":"144","id":"NTFILE8F5Di6AAjqCpAz3S","market":"us","size":0}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Proposed Sale Of Securities","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"关联方拟减持公告","pubTime":"2026-03-11 12:00","pubTimestamp":1773201600,"title_zh":"Form 144 - Report of proposed sale of securities","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20989169","market":"us","labels":[],"media":"sec.gov","original_id":"AN114036126008354-ATAI","pdf_url":"","pub_time":1773028800000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ATAI","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126008354/0001140361-26-008354-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 1.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126008354/ef20067368_ex1-1.htm","primary":true,"translateUrl":"","linkName":"ef20067368_ex1-1.htm","type":"EX-1.1","id":"NTFILEHz3MXiwUyiJKLHR4","market":"us","size":267638},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126008354/ef20067368_8k.htm","primary":false,"translateUrl":"","linkName":"ef20067368_8k.htm","type":"8-K","id":"NTFILEqVXLvQvbF2JRHjaA","market":"us","size":33049}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-03-09 12:00","pubTimestamp":1773028800,"title_zh":"Form 8-K - Current report","summary_en":"Item 1.01: Entry into a Material Definitive Agreement;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"第1.01项：签订重大最终协议；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20989166","market":"us","labels":[],"media":"sec.gov","original_id":"AN114036126008296-ATAI","pdf_url":"","pub_time":1772773200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 8-K - Current report","symbol":"ATAI","title":"Form 8-K - Current report","titleType":"重要事件披露","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126008296/0001140361-26-008296-index.htm","us_notice_code":"Form 8-K","us_title_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"EXHIBIT 99.1","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126008296/ef20066721_ex99-1.htm","primary":true,"translateUrl":"","linkName":"ef20066721_ex99-1.htm","type":"EX-99.1","id":"NTFILEG3cVxcqzhrs4fSfF","market":"us","size":245316},{"description":"8-K","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126008296/ef20066721_8k.htm","primary":false,"translateUrl":"","linkName":"ef20066721_8k.htm","type":"8-K","id":"NTFILE714rSsBinEgteHGp","market":"us","size":30533}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Major Issues Report","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"重要事件披露","pubTime":"2026-03-06 13:00","pubTimestamp":1772773200,"title_zh":"Form 8-K - Current report","summary_en":"Item 8.01: Other Events;\nItem 9.01: Financial Statements and Exhibits","summary_zh":"项目8.01：其他事件；项目9.01：财务报表和附件","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20989165","market":"us","labels":[],"media":"sec.gov","original_id":"AN119312526096926-ATAI","pdf_url":"","pub_time":1772773200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","symbol":"ATAI","title":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","titleType":"年度报告","type":"usFinancials","url":"https://www.sec.gov/Archives/edgar/data/2081043/000119312526096926/0001193125-26-096926-index.htm","us_notice_code":"Form 10-K","us_title_en":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"10-K","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000119312526096926/atai-20251231.htm","primary":true,"translateUrl":"","linkName":"atai-20251231.htm","type":"10-K","id":"NTFILE6weDgaQMrejfpYtT","market":"us","size":6415947},{"description":"EX-4.2","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000119312526096926/atai-ex4_2.htm","primary":false,"translateUrl":"","linkName":"atai-ex4_2.htm","type":"EX-4.2","id":"NTFILE3BBRz3HDMEiZdyy5","market":"us","size":46407},{"description":"EX-10.7","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000119312526096926/atai-ex10_7.htm","primary":false,"translateUrl":"","linkName":"atai-ex10_7.htm","type":"EX-10.7","id":"NTFILEAtyz5x4QjzbLtmXW","market":"us","size":60347},{"description":"EX-10.8","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000119312526096926/atai-ex10_8.htm","primary":false,"translateUrl":"","linkName":"atai-ex10_8.htm","type":"EX-10.8","id":"NTFILE9JGAFkYJH1QFkj3d","market":"us","size":54070},{"description":"EX-10.36","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000119312526096926/atai-ex10_36.htm","primary":false,"translateUrl":"","linkName":"atai-ex10_36.htm","type":"EX-10.36","id":"NTFILE26je3P7hoxeTGvHw","market":"us","size":67851},{"description":"EX-10.37","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000119312526096926/atai-ex10_37.htm","primary":false,"translateUrl":"","linkName":"atai-ex10_37.htm","type":"EX-10.37","id":"NTFILE4EudUCdcGLB3C4sw","market":"us","size":225300},{"description":"EX-19.1","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000119312526096926/atai-ex19_1.htm","primary":false,"translateUrl":"","linkName":"atai-ex19_1.htm","type":"EX-19.1","id":"NTFILEDbYSqmcxeh7CsXcC","market":"us","size":84165},{"description":"EX-21.1","seq":8,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000119312526096926/atai-ex21_1.htm","primary":false,"translateUrl":"","linkName":"atai-ex21_1.htm","type":"EX-21.1","id":"NTFILE12PkRuuiqatBzyjQ","market":"us","size":13858},{"description":"EX-23.1","seq":9,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000119312526096926/atai-ex23_1.htm","primary":false,"translateUrl":"","linkName":"atai-ex23_1.htm","type":"EX-23.1","id":"NTFILEHZGnwcP19gthwyUu","market":"us","size":4897},{"description":"EX-31.1","seq":10,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000119312526096926/atai-ex31_1.htm","primary":false,"translateUrl":"","linkName":"atai-ex31_1.htm","type":"EX-31.1","id":"NTFILE4EktMxMU842rRhaA","market":"us","size":16451},{"description":"EX-31.2","seq":11,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000119312526096926/atai-ex31_2.htm","primary":false,"translateUrl":"","linkName":"atai-ex31_2.htm","type":"EX-31.2","id":"NTFILEFzh4qB9quXdcN9Ag","market":"us","size":16513},{"description":"EX-32.1","seq":12,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000119312526096926/atai-ex32_1.htm","primary":false,"translateUrl":"","linkName":"atai-ex32_1.htm","type":"EX-32.1","id":"NTFILEETAV6QYFE2JsFAhH","market":"us","size":10658},{"description":"EX-32.2","seq":13,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000119312526096926/atai-ex32_2.htm","primary":false,"translateUrl":"","linkName":"atai-ex32_2.htm","type":"EX-32.2","id":"NTFILEB88sZcXcxv13hCSY","market":"us","size":10413},{"description":"EX-97.1","seq":14,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000119312526096926/atai-ex97_1.htm","primary":false,"translateUrl":"","linkName":"atai-ex97_1.htm","type":"EX-97.1","id":"NTFILE3g5evKiyLYqNbNR7","market":"us","size":44116},{"description":"GRAPHIC","seq":15,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000119312526096926/img143717285_0.gif","primary":false,"translateUrl":"","linkName":"img143717285_0.gif","type":"GRAPHIC","id":"NTFILEH9jeTtjnvAYkRutZ","market":"us","size":122136},{"description":"GRAPHIC","seq":16,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000119312526096926/img143717285_1.gif","primary":false,"translateUrl":"","linkName":"img143717285_1.gif","type":"GRAPHIC","id":"NTFILEHywAavnRsoNjDoTR","market":"us","size":209086},{"description":"GRAPHIC","seq":17,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000119312526096926/img171982322_0.gif","primary":false,"translateUrl":"","linkName":"img171982322_0.gif","type":"GRAPHIC","id":"NTFILEGx5NHpsLqomHx1uc","market":"us","size":5286},{"description":"GRAPHIC","seq":18,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000119312526096926/img216340584_0.jpg","primary":false,"translateUrl":"","linkName":"img216340584_0.jpg","type":"GRAPHIC","id":"NTFILE8XSZX4J8pEEMKFNz","market":"us","size":186913}],"type_name":"财务报告","type_name_en":"Financial Report","titleTypeEn":"Annual Report","us_type":"usFinancials","us_type_zh":"财务报告","earn_infos":[],"event_type":"important_notice","event_name":"年度报告","pubTime":"2026-03-06 13:00","pubTimestamp":1772773200,"title_zh":"Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0},{"cdn_pdf":false,"hasAttachments":true,"id":"20989164","market":"us","labels":[],"media":"sec.gov","original_id":"AN114036126008297-ATAI","pdf_url":"","pub_time":1772773200000,"showTitleType":true,"size":0,"source":"sec_us","summary":"Form S-8 - Securities to be offered to employees in employee benefit plans","symbol":"ATAI","title":"Form S-8 - Securities to be offered to employees in employee benefit plans","titleType":"员工持股计划","type":"usAnnouncement","url":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126008297/0001140361-26-008297-index.htm","us_notice_code":"Form S-8","us_title_en":"Form S-8 - Securities to be offered to employees in employee benefit plans","is_important":0,"hasEarnInfos":false,"gpt_zh_title":"","gpt_en_title":"","attachments":[{"description":"S-8","seq":1,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126008297/ef20064917_s8.htm","primary":true,"translateUrl":"","linkName":"ef20064917_s8.htm","type":"S-8","id":"NTFILET8HY6kJ1s68MVSkV","market":"us","size":49937},{"description":"EXHIBIT 5.1","seq":2,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126008297/ef20064917_ex5-1.htm","primary":false,"translateUrl":"","linkName":"ef20064917_ex5-1.htm","type":"EX-5.1","id":"NTFILEHPBJrrpZaP9ANJev","market":"us","size":11437},{"description":"EXHIBIT 23.1","seq":3,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126008297/ef20064917_ex23-1.htm","primary":false,"translateUrl":"","linkName":"ef20064917_ex23-1.htm","type":"EX-23.1","id":"NTFILESkZfcwM31iasDN6C","market":"us","size":2166},{"description":"EXHIBIT 23.2","seq":4,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126008297/ef20064917_ex23-2.htm","primary":false,"translateUrl":"","linkName":"ef20064917_ex23-2.htm","type":"EX-23.2","id":"NTFILE4r14qwj4URc8F5t5","market":"us","size":1605},{"description":"","seq":5,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126008297/ef20064917_ex107.htm","primary":false,"translateUrl":"","linkName":"ef20064917_ex107.htm","type":"EX-FILING FEES","id":"NTFILEE7GxcadESE2eXf4H","market":"us","size":17363},{"description":"","seq":6,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126008297/image00001.jpg","primary":false,"translateUrl":"","linkName":"image00001.jpg","type":"GRAPHIC","id":"NTFILEEseynR3SidAaGi1N","market":"us","size":3618},{"description":"","seq":7,"linkUrl":"https://www.sec.gov/Archives/edgar/data/2081043/000114036126008297/image00002.jpg","primary":false,"translateUrl":"","linkName":"image00002.jpg","type":"GRAPHIC","id":"NTFILE3p9xsEAZUzKyLNRS","market":"us","size":2161}],"type_name":"交易披露","type_name_en":"Transaction Related","titleTypeEn":"Employee Stock Ownership","us_type":"usAnnouncement","us_type_zh":"交易披露","earn_infos":[],"event_type":"important_notice","event_name":"员工持股计划","pubTime":"2026-03-06 13:00","pubTimestamp":1772773200,"title_zh":"Form S-8 - Securities to be offered to employees in employee benefit plans","summary_en":"","summary_zh":"","notice_type":"","filling_tag":"","gpt_icon":0}],"currentPage":1,"bottom":false},"companyData":{"profile":{"websiteUrl":"http://www.ataibeckley.com;ir.ataibeckley.com","stockEarnings":[{"period":"1week","weight":0.3415},{"period":"1month","weight":0.7271},{"period":"3month","weight":0.7742},{"period":"6month","weight":0.9643},{"period":"1year","weight":1.6481},{"period":"ytd","weight":0.7482}],"compareEarnings":[{"period":"1week","weight":-0.0013},{"period":"1month","weight":0.0005},{"period":"3month","weight":0.0571},{"period":"6month","weight":0.0854},{"period":"1year","weight":0.2027},{"period":"ytd","weight":0.1009}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"AtaiBeckley Inc.于2020年9月10日根据荷兰法律注册。2021年1月11日，更名为ATAI Life Sciences B.V.。2025年11月5日，更名为Atai Beckley N.V.。2026年1月2日，公司名称变更为AtaiBeckley Inc.，并转变为根据特拉华州法律注册成立的公司。该公司是一家临床阶段的生物技术公司，专注于为难以治疗的心理健康疾病开发新型的、基于迷幻药的神经可塑性药物。其研发管线包括针对难治性抑郁症和社交焦虑障碍的研究项目，以及一个针对新型非致幻化合物的药物发现项目。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.057026},{"month":2,"riseRate":0.6,"avgChangeRate":0.037147},{"month":3,"riseRate":0.4,"avgChangeRate":-0.050898},{"month":4,"riseRate":0.8,"avgChangeRate":0.036247},{"month":5,"riseRate":0.4,"avgChangeRate":0.057357},{"month":6,"riseRate":0.2,"avgChangeRate":-0.033198},{"month":7,"riseRate":0.833333,"avgChangeRate":0.251281},{"month":8,"riseRate":0.6,"avgChangeRate":-0.017917},{"month":9,"riseRate":0.2,"avgChangeRate":-0.094209},{"month":10,"riseRate":0.2,"avgChangeRate":-0.030207},{"month":11,"riseRate":0.4,"avgChangeRate":0.02801},{"month":12,"riseRate":0.4,"avgChangeRate":-0.079437}],"exchange":"NASDAQ","name":"Atai Beckley Inc","nameEN":"Atai Beckley Inc"},"aProfile":null}}}